CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q2 2021$3,323,000
-75.1%
25,258
-75.6%
0.00%
-80.0%
Q1 2021$13,323,000
-32.4%
103,376
-12.5%
0.01%
-33.3%
Q4 2020$19,700,000
+28.1%
118,121
+18.5%
0.02%
+7.1%
Q3 2020$15,383,000
+17.3%
99,680
+12.4%
0.01%
+7.7%
Q2 2020$13,115,000
+114.9%
88,678
+63.6%
0.01%
+85.7%
Q1 2020$6,103,000
-18.5%
54,200
+0.7%
0.01%0.0%
Q4 2019$7,485,000
+80.3%
53,800
+24.8%
0.01%
+75.0%
Q3 2019$4,151,000
+46.5%
43,100
+75.2%
0.00%
+33.3%
Q2 2019$2,833,000
-11.4%
24,600
-9.5%
0.00%
-25.0%
Q1 2019$3,198,000
+18.2%
27,175
-37.1%
0.00%0.0%
Q4 2018$2,706,000
-15.7%
43,192
-4.6%
0.00%0.0%
Q3 2018$3,209,000
+70.6%
45,292
+60.1%
0.00%
+33.3%
Q2 2018$1,881,000
-35.0%
28,281
-36.1%
0.00%
-25.0%
Q1 2018$2,894,000
+256.8%
44,255
+118.7%
0.00%
+300.0%
Q4 2017$811,000
+13.7%
20,235
+2.9%
0.00%0.0%
Q3 2017$713,000
+65.8%
19,658
+26.8%
0.00%0.0%
Q2 2017$430,00015,5000.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2020
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,797,745$265,886,00019.06%
RA Capital Management 4,914,955$726,922,00014.16%
Sofinnova Investments, Inc. 1,109,874$164,150,00010.35%
Eventide Asset Management 1,709,848$252,887,0005.50%
Asymmetry Capital Management, L.P. 47,599$7,040,0005.39%
BERYLSON CAPITAL PARTNERS, LLC 58,200$8,608,0005.30%
Avoro Capital Advisors LLC 1,750,000$258,825,0005.12%
Eversept Partners, LP 220,344$32,588,8784.47%
Spyglass Capital Management LLC 452,104$66,866,0004.14%
Orbimed Advisors 1,562,986$231,166,0003.25%
View complete list of ASCENDIS PHARMA A/S shareholders